Fig. 2
Kaplan–Meier progression free survival analysis after treatment with tamoxifen. Median PFS was 10 months (95% CI 6.4–24.6)
Fig. 2 | Clinical Sarcoma Research
Kaplan–Meier progression free survival analysis after treatment with tamoxifen. Median PFS was 10 months (95% CI 6.4–24.6)
Clinical Sarcoma Research